Shanghai - Delayed Quote CNY
Shanghai Serum Bio-Technology Co., Ltd. (688163.SS)
17.41
+0.23
+(1.34%)
At close: 3:00:05 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
194,235.85
194,915.92
190,144.20
174,221.01
208,693.63
Cost of Revenue
41,714.89
42,770.56
46,187.10
28,276.58
34,055.65
Gross Profit
152,520.95
152,145.37
143,957.10
145,944.43
174,637.98
Operating Expense
96,968.67
98,755.32
105,964.02
85,296.51
83,403.04
Operating Income
55,552.29
53,390.05
37,993.08
60,647.92
91,234.94
Net Non Operating Interest Income Expense
1,596.08
1,705.81
2,190.01
2,183.18
759.31
Pretax Income
52,817.67
50,566.05
45,415.27
74,038.15
87,877.43
Tax Provision
6,244.74
6,275.65
6,640.94
9,839.87
11,394.63
Net Income Common Stockholders
46,572.93
44,290.40
38,774.33
64,198.28
76,482.80
Basic EPS
0.43
0.41
0.36
0.63
0.94
Diluted EPS
0.43
0.41
0.36
0.63
0.94
Basic Average Shares
102,466.67
108,025.37
107,706.48
101,902.04
81,364.68
Diluted Average Shares
102,466.67
108,025.37
107,706.48
101,902.04
81,364.68
Total Operating Income as Reported
54,279
51,984.95
45,983.98
74,662.18
88,209.76
Rent Expense Supplemental
--
--
--
14.61
7.60
Total Expenses
138,683.56
141,525.87
152,151.12
113,573.09
117,458.69
Net Income from Continuing & Discontinued Operation
46,572.93
44,290.40
38,774.33
64,198.28
76,482.80
Normalized Income
53,997.36
50,457.36
40,532.66
66,002.89
78,855.33
Interest Income
1,952.91
2,161.84
2,881.19
2,870.56
1,484.49
Interest Expense
316.41
430.19
648.26
680.46
710.56
Net Interest Income
1,596.08
1,705.81
2,190.01
2,183.18
759.31
EBIT
53,134.09
50,996.24
46,063.52
74,718.61
88,587.99
EBITDA
53,134.09
71,100.15
63,220.30
89,615.23
103,623.11
Reconciled Cost of Revenue
41,714.89
42,770.56
46,187.10
28,276.58
34,055.65
Reconciled Depreciation
--
20,103.91
17,156.77
14,896.62
15,035.12
Net Income from Continuing Operation Net Minority Interest
46,572.93
44,290.40
38,774.33
64,198.28
76,482.80
Total Unusual Items Excluding Goodwill
-8,419.94
-7,040.78
-2,059.48
-2,081.20
-2,726
Total Unusual Items
-8,419.94
-7,040.78
-2,059.48
-2,081.20
-2,726
Normalized EBITDA
61,554.02
78,140.93
65,279.78
91,696.43
106,349.11
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-995.51
-873.82
-301.15
-276.60
-353.47
12/31/2021 - 3/11/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade